On Tuesday, May 7, the U.S. Court of Appeals for the Federal Circuit will hear argument in a long-awaited appeal addressing the inventorship of the Nobel Prize-winning CRISPR technology. The case is the latest in a continuing legal battle between two groups of innovators, each asserting patent rights to key aspects of the groundbreaking technology.
Recent Posts
- Other Barks and Bites for Friday, May 17: Senate AI Working Group Releases AI Policy Roadmap; Voice Actors Accuse AI Company of Stealing Their Voices; USPTO Accidentally Publishes Patent Application Titles
- MLC Expands Blanket License Enforcement Campaign With Lawsuit Against Spotify
- CAFC Dismisses Bid for PREP Act Protection Due to Lack of Jurisdiction Under Collateral Order Doctrine
- Chestek Takes Challenge of USPTO Domicile Address Rule for Trademark Applicants to High Court
- Why IP Rights Expire and Why They Must Be Strong While They Last